Ubs Group Ag Rapid Micro Biosystems, Inc. Transaction History

Ubs Group Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.66 - $1.0 $97 - $148	-148 Reduced 60.16%	98 $0
Q1 2024 May 13, 2024	BUY	$0.9 - $1.1 $221 - $270	246 New	246 $0
Q4 2022 Feb 08, 2023	SELL	$1.13 - $3.5 $1,658 - $5,138	-1,468 Reduced 71.23%	593 $0
Q3 2022 Nov 10, 2022	SELL	$2.95 - $4.66 $7,578 - $11,971	-2,569 Reduced 55.49%	2,061 $6,000
Q2 2022 Aug 10, 2022	SELL	$2.49 - $6.76 $786 - $2,136	-316 Reduced 6.39%	4,630 $20,000
Q1 2022 May 16, 2022	SELL	$5.76 - $10.83 $11,514 - $21,649	-1,999 Reduced 28.78%	4,946 $34,000
Q4 2021 Feb 14, 2022	BUY	$9.41 - $22.19 $60,289 - $142,171	6,407 Added 1190.89%	6,945 $74,000
Q3 2021 Nov 15, 2021	BUY	$17.88 - $24.8 $9,619 - $13,342	538 New	538 $10,000

17.7M

Ticker RPID
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,389,100
Market Cap $48.8M
Description
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumab...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.